Publicacións en colaboración con investigadores/as de Instituto Nacional de Cardiología (51)

2024

  1. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

  2. Mitral Valve Transcatheter Edge-to-Edge Repair: 1-Year Outcomes From the MiCLASP Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 7, pp. 890-903

  3. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study

    Circulation: Heart Failure, Vol. 17, Núm. 1, pp. E011105

2023

  1. Impact of Complete Revascularization in the ISCHEMIA Trial

    Journal of the American College of Cardiology, Vol. 82, Núm. 12, pp. 1175-1188

  2. Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial

    JACC: Heart Failure, Vol. 11, Núm. 12, pp. 1729-1738

2022

  1. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

    American Heart Journal, Vol. 248, pp. 72-83

  2. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

  3. Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry

    European Journal of Preventive Cardiology, Vol. 29, Núm. 15, pp. 1945-1954

  4. Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy

    Hellenic Journal of Cardiology, Vol. 67, pp. 9-18

  5. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

    New England Journal of Medicine, Vol. 387, Núm. 11, pp. 978-988

2021

  1. Acute right ventricular failure in COVID-19 infection: A case series

    Journal of Cardiology Cases, Vol. 24, Núm. 1, pp. 45-48

  2. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

  3. Case Report: A Rare Case of a Ventricular Perivascular Epithelioid Cell Tumor With Histologic Characteristics That Resembled a Primary Cardiac Rhabdomyoma

    Frontiers in Cardiovascular Medicine, Vol. 8

  4. Circulatory support with venoarterial ecmo in a patient with biventricular takotsubo cardiomyopathy

    Archivos de Cardiologia de Mexico, Vol. 91, Núm. 1, pp. 100-104

  5. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: The ESC EORP Cardiomyopathy/Myocarditis Registry

    European Heart Journal Cardiovascular Imaging, Vol. 22, Núm. 7, pp. 781-789

  6. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

  7. Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes

    International Journal of Cardiovascular Imaging, Vol. 37, Núm. 3, pp. 953-964

  8. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4685-4692

  9. Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging

    Journal of Clinical Medicine, Vol. 10, Núm. 16

2020

  1. Atrial fibrillation in cardiac surgery

    Archivos de Cardiologia de Mexico, Vol. 89, Núm. 4, pp. 319-329